— Know what they know.
Not Investment Advice
Also trades as: 6855.HK (HKSE) · $vol 10M · AAPGV (OTC) · $vol 9M · ASPHF (OTC) · $vol 0M

AAPG NASDAQ

Ascentage Pharma Group International
1W: -8.0% 1M: -1.6% 3M: -20.0% YTD: -44.4% 1Y: -58.7%
$14.85
-0.60 (-3.88%)
 
Weekly Expected Move ±10.2%
$12 $14 $15 $17 $18
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 39 · $1.4B mcap · 7M float · 0.141% daily turnover · Short 52% of daily vol
Credit Risk of going bust: higher than 70% of companies Debt: 18.6% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.61 (down 96%), Ascentage Pharma Group International would be worth roughly what it owes.
Total debt $314.8M against a stock market value of $1.38B.
Distance to default 3.42 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $267.2M (short-term plus half of long-term), stock volatility 59.8%; Altman Z'' -9.70. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Oct Typical
☁️
Cloudy
+0.0% YTD avg
2026 Now
☁️
Cloudy
Tracking typical
20yr Avg YTD
—
2026 YTD
—
Typical Vol
61%
Annualized
Monthly Weather Forecast
Jan
20yr
⛈️
-3.1%
50% win 42% vol
Feb
20yr
💨
+3.7%
50% win 57% vol
Mar
20yr
💨
+7.2%
50% win 78% vol
Apr
20yr
💨
+3.6%
50% win 82% vol
May
20yr
⛈️
-6.3%
0% win 57% vol
Jun
20yr
💨
+24.6%
50% win 60% vol
Jul
20yr
⛈️
-3.4%
0% win 57% vol
Aug
20yr
💨
+6.4%
50% win 66% vol
Sep
20yr
⛈️
-6.3%
0% win 46% vol
Oct
20yr
⛈️
-12.3%
0% win 61% vol
Now: -10.2%
Nov
20yr
⛈️
-2.8%
0% win 39% vol
Dec
20yr
⛈️
-19.3%
0% win 72% vol

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms